GWENITA ROBERTS: Open Payments
NPI 1629093455 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$385 in 16 payments from 9 companies in 2025. Trend: 2023 $125 · 2024 $180 · 2025 $385
Food & beverage: $385
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 3 | $79 |
| Exact Sciences Corporation | 3 | $69 |
| Verona Pharma, Inc. | 2 | $58 |
| PFIZER INC. | 2 | $46 |
| AstraZeneca Pharmaceuticals LP | 2 | $37 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $30 |
| Novo Nordisk Inc | 1 | $28 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $23 |
| Amgen Inc. | 1 | $15 |
Products named: JARDIANCE, The Cologuard Plus Collection Kit, Ohtuvayre, PAXLOVID, AIRSUPRA, JOURNAVX, Ozempic, OTEZLA.
Industry payments across TX — which companies pay providers there.
